logo
  

Spire Inc. Q2 Profit Increases, but misses estimates

Spire Inc. (SR) released a profit for its second quarter that increased from last year but missed the Street estimates.

The company's bottom line came in at $204.3 million, or $3.58 per share. This compares with $179.2 million, or $3.33 per share, in last year's second quarter.

Excluding items, Spire Inc. reported adjusted earnings of $196.6 million or $3.45 per share for the period.

Analysts on average had expected the company to earn $3.72 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 0.4% to $1.128 billion from $1.123 billion last year.

Spire Inc. earnings at a glance (GAAP) :

-Earnings (Q2): $204.3 Mln. vs. $179.2 Mln. last year.
-EPS (Q2): $3.58 vs. $3.33 last year.
-Revenue (Q2): $1.128 Bln vs. $1.123 Bln last year.

-Guidance:
Full year EPS guidance: $4.25 to $4.45

For comments and feedback contact: editorial@rttnews.com

In this week's video, we highlight Roche's pioneering approach for weight loss and glucose control. Meanwhile, the EMA has taken strict action on certain preterm birth drugs and Bayer has downsized its staff. In a breakthrough for cancer treatment, the FDA has approved a groundbreaking T-cell engager therapy. Amid progress, setbacks emerge as another ALS drug study has faltered, following closely on the heels of Amylyx Pharma's recent decision to withdraw its FDA-approved ALS drug, Relyvrio.

View More Videos
RELATED NEWS
Follow RTT